Back

Impact of ESC-endorsed high ischemic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI

13 March 2021 (17:40 - 18:20)
Organised by:
Congress Presentation Part of: ACVC Research Prize Percutaneous Coronary Intervention (PCI) ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Hao-Yu Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

3 More presentations in this session

Presentation thumbnail
The interplay between myocardial bridging and coronary spasm in patients with myocardial infarction and non-obstructive coronary arteries: pathogenic and prognostic implications
Doctor R. Montone (Rome, IT)
Abstract Video
Presentation thumbnail
Impella RP versus pharmacologic vasoactive treatment in profound cardiogenic shock due to right ventricular failure: Unloading and end-organ perfusion in a large animal model
Doctor J. Josiassen (Copenhagen, DK)
Abstract Video
Presentation thumbnail
Preclinical testing of a novel pericardial left ventricular assist device (PALVAD)
Doctor A. Premawardhana (Leicester, GB)
Abstract Video

Access the full session

Session thumbnail
ACVC Research Prize
Video

The Event

Event poster

ACVC 2021

13 March 2021 17:40 CET
You may be interested in
thumbnail
Congress Presentation
'My bleeding heart': tamponade – detection and management
thumbnail
Congress Session
Complex PCI in practice: tips and tricks to take home
thumbnail
Congress Presentation
A patient with recent non-ST elevation myocardial infarction and percutaneous coronary intervention requiring cancer surgery: what do the guidelines say?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources